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Abstract
Background: Women in Iran are in great need of effective substance abuse services. The current study was
conducted to investigate the effectiveness of motivational interviewing (MI) for women in treatment for drug use in
Iran.
Method: The sample (N = 60) included women in a drug treatment center in Qazvin (Iran) from August to
December of 2017. The research sample included 60 female drug users randomly assigned to MI or Standard Care
(SC). Prior to randomization women completed a baseline questionnaire and the Relapse Prediction Scale (RPS),
which measures desire (urge) to use and probability of using/not using in risky situations (self-efficacy). MI consisted
of eight 60-min group sessions over a 1-month period, twice weekly. At 2-months follow-up, data were gathered
using a questionnaire similar to baseline. Mixed Model Analysis were used to determine group differences.
Results: Mean age of participants was 30 years and average addiction duration was 7 years. Although the scores of
the desire to use and the probability of drug use were not significant before the intervention, after the intervention,
scores on desire to use and probability of use improved about 81.1% (F: 2230.15, P < 0.001, degrees of freedom: 63,
15) and 81.9%, (F: 749.39, P < 0.001, degrees of freedom: 79, 77), respectively, compared to those of control group.
Conclusion: The results showed that motivational interviewing could decrease desire to use and probability of use
among female drug users. Motivational interviewing could play an important role in improving women’s health in
Iran.
Trial registration: IRCT registration number: IRCT20140907019077N4
Registration date: 2017-12-12, 1396/09/21
Registration timing: registered_while_recruiting
Last update: 2017-12-12, 1396/09/21
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Background
Women and drug abuse
Given Iran’s proximity to a major opioid trade route, illicit
drug use is a major problem in Iran and opioids in particular
are readily available [1–4]. Due to stigma, prevalence re-
search on drug use is scant, although use of stimulants and
injection drugs appears to have increased over time.
Amin-Esmaeli et al., (2016) [4] studied prevalence of
substance use disorders in Iran (N = 7841; N, women =
4475). Prevalence of 12-month use disorder for any drug
was 2.44% with opioid use disorder most common (2.23%)
followed by cannabis (.56%) and amphetamines (.39%).
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Results
The average age of participants was 30 years old and
both groups were not significantly different in terms of
education and income P > 0.05. Figure 1 shows flow dia-
gram of the study. The highest rate of substance use was
associated with methamphetamine and heroin in both
groups (see Table 2 for description of other drugs). An
average duration of addiction was reported as 7 years.
Also, women reported seeking treatment 2–3 times pre-
viously. Both groups had relatives who were drug users,
particularly their husbands. In brief, both groups were
not significantly different in terms of demographics
characteristics, P > 0.05. (See Table 3.)
The descriptive statistics of the RPS are provided in
the Table 4. As observed in the table, the results reflect
the effectiveness of MI (P > 0.001).
Discussion
As compared to women randomized to standard care
(SC), women randomized to motivational interviewing
(MI) significantly reduced both desire (urge) to use sub-
stances and reported probability of using in tempting situ-
ations (i.e., self-efficacy improved). Results are consistent
with prior research in the filed [24].
Addiction is often a relapsing condition (most of the
women had been in treatment multiple times) and is as-
sociated with much stigma and ambivalence around
change. Therefore, MI may be particularly useful in re-
ducing substance abuse in that it meets women where
they are in change (or cycling through stages of change),
assists women to resolve ambivalence, and is non-
judgmental and person-centered [20].
Limitation
Results may not generalize to addicted women in other set-
tings since the samples were recruited from one rehabilita-
tion center. Women were in a treatment program when
they responded, which might have biased their responses.
Also, there was no behavioral outcome included such as ac-
tual drug use following release from the facility. In addition,
differences in treatment exposure (MI and SC had 8 and 4
sessions, respectively) could account for group differences.
Also we did not assess family support, which may impact
relapse.
Conclusion
Results showed that motivational interviewing can de-
crease desire (urge) to use and reported probability of
use (i.e., improve self-efficacy) among female drug users.
Motivational interviewing could play an important role
in improving women’s health in Iran, although it is not
regularly used currently in Iran. This study is a critical
first step at adapting and evaluating MI in Iranian
women to reduce substance use. It is important to evalu-
ate MI and TTM-informed interventions in non-
Western countries. Findings are encouraging and future
work should evaluate behavioral outcomes in larger
samples.
Abbreviation
RPS: Relapse Prediction Scale
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